Astera Labs, Inc. (ALAB)
(Delayed Data from NSDQ)
$60.50 USD
+2.96 (5.14%)
Updated Jul 2, 2024 04:00 PM ET
After-Market: $60.40 -0.10 (-0.17%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Balance Sheet
Fiscal Year End for Astera Labs, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 149 | 163 | -99,999 | -99,999 | -99,999 |
Receivables | 8 | 11 | NA | NA | NA |
Notes Receivable | 0 | 0 | NA | NA | NA |
Inventories | 24 | 29 | NA | NA | NA |
Other Current Assets | 4 | 3 | NA | NA | NA |
Total Current Assets | 186 | 206 | NA | NA | NA |
Net Property & Equipment | 5 | 4 | NA | NA | NA |
Investments & Advances | 0 | 0 | NA | NA | NA |
Other Non-Current Assets | 0 | 0 | NA | NA | NA |
Deferred Charges | 0 | 0 | NA | NA | NA |
Intangibles | 0 | 0 | NA | NA | NA |
Deposits & Other Assets | 6 | 2 | NA | NA | NA |
Total Assets | 196 | 212 | NA | NA | NA |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | NA | NA | NA |
Accounts Payable | 6 | 10 | NA | NA | NA |
Current Portion Long-Term Debt | 0 | 0 | NA | NA | NA |
Current Portion Capital Leases | 0 | 0 | NA | NA | NA |
Accrued Expenses | 29 | 30 | NA | NA | NA |
Income Taxes Payable | 0 | 0 | NA | NA | NA |
Other Current Liabilities | 0 | 0 | NA | NA | NA |
Total Current Liabilities | 35 | 40 | NA | NA | NA |
Mortgages | 0 | 0 | NA | NA | NA |
Deferred Taxes/Income | 0 | 0 | NA | NA | NA |
Convertible Debt | 0 | 0 | NA | NA | NA |
Long-Term Debt | 0 | 0 | NA | NA | NA |
Non-Current Capital Leases | 0 | 0 | NA | NA | NA |
Other Non-Current Liabilities | 259 | 257 | NA | NA | NA |
Minority Interest (Liabilities) | 0 | 0 | NA | NA | NA |
Total Liabilities | 294 | 297 | NA | NA | NA |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | NA | NA | NA |
Common Stock (Par) | 0 | 0 | NA | NA | NA |
Capital Surplus | 27 | 14 | NA | NA | NA |
Retained Earnings | -125 | -99 | NA | NA | NA |
Other Equity | 0 | 0 | NA | NA | NA |
Treasury Stock | 0 | 0 | NA | NA | NA |
Total Shareholder's Equity | -98 | -85 | NA | NA | NA |
Total Liabilities & Shareholder's Equity | 196 | 212 | NA | NA | NA |
Total Common Equity | -98 | -85 | 0 | 0 | 0 |
Shares Outstanding | NA | NA | NA | NA | NA |
Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fiscal Year End for Astera Labs, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 801 | 149 | -99,999 | -99,999 | 0 |
Receivables | 17 | 8 | NA | NA | 0 |
Notes Receivable | 0 | 0 | NA | NA | 0 |
Inventories | 30 | 24 | NA | NA | 0 |
Other Current Assets | 7 | 4 | NA | NA | 0 |
Total Current Assets | 854 | 186 | NA | NA | 0 |
Net Property & Equipment | 8 | 5 | NA | NA | 0 |
Investments & Advances | 0 | 0 | NA | NA | 0 |
Other Non-Current Assets | 0 | 0 | NA | NA | 0 |
Deferred Charges | 0 | 0 | NA | NA | 0 |
Intangibles | 0 | 0 | NA | NA | 0 |
Deposits & Other Assets | 3 | 6 | NA | NA | 0 |
Total Assets | 865 | 196 | NA | NA | 0 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | NA | NA | 0 |
Accounts Payable | 11 | 6 | NA | NA | 0 |
Current Portion Long-Term Debt | 0 | 0 | NA | NA | 0 |
Current Portion Capital Leases | 0 | 0 | NA | NA | 0 |
Accrued Expenses | 34 | 29 | NA | NA | 0 |
Income Taxes Payable | 0 | 0 | NA | NA | 0 |
Other Current Liabilities | 0 | 0 | NA | NA | 0 |
Total Current Liabilities | 46 | 35 | NA | NA | 0 |
Mortgages | 0 | 0 | NA | NA | 0 |
Deferred Taxes/Income | 0 | 0 | NA | NA | 0 |
Convertible Debt | 0 | 0 | NA | NA | 0 |
Long-Term Debt | 0 | 0 | NA | NA | 0 |
Non-Current Capital Leases | 0 | 0 | NA | NA | 0 |
Other Non-Current Liabilities | 11 | NA | NA | 0 | |
Minority Interest (Liabilities) | 0 | 0 | NA | NA | 0 |
Total Liabilities | 56 | 294 | NA | NA | 0 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | NA | NA | 0 |
Common Stock (Par) | 0 | 0 | NA | NA | 0 |
Capital Surplus | 1,027 | 27 | NA | NA | 0 |
Retained Earnings | -218 | -125 | NA | NA | 0 |
Other Equity | 0 | 0 | NA | NA | 0 |
Treasury Stock | 0 | 0 | NA | NA | 0 |
Total Shareholder's Equity | 809 | -98 | NA | NA | 0 |
Total Liabilities & Shareholder's Equity | 865 | 196 | NA | NA | 0 |
Total Common Equity | 809 | -98 | 0 | 0 | 0 |
Shares Outstanding | 152.50 | NA | NA | NA | NA |
Book Value Per Share | 5.30 | 0.00 | 0.00 | 0.00 | 0.00 |